Literature DB >> 21819252

Gynecologic oncologists and ovarian cancer treatment: avenues for improved survival.

Sherri L Stewart1, Sun Hee Rim, Thomas B Richards.   

Abstract

Ovarian cancer is the deadliest gynecologic malignancy in the United States. Evidence-based interventions for the prevention and early detection of ovarian cancer do not currently exist. However, several treatment guidelines, including the receipt of treatment from a gynecologic oncologist, have been shown to result in improved survival from ovarian cancer.

Entities:  

Mesh：

Year:  2011        PMID： 21819252     DOI： 10.1089/jwh.2011.3053

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN： 1540-9996            Impact factor:   2.681


  14 in total

1.  The Effect of Gynecologic Oncologist Availability on Ovarian Cancer Mortality.

Authors:  Sherri L Stewart; Darryl Cooney; Shawn Hirsch; Lauren Westervelt; Thomas B Richards; Sun Hee Rim; Cheryll C Thomas
Journal:  World J Obstet Gynecol       Date:  2014-05-10

2.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

Review 3.  Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers.

Authors:  Mingo M H Yung; Michelle K Y Siu; Hextan Y S Ngan; David W Chan; Karen K L Chan
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

4.  Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.

Authors:  Sherri L Stewart; Julie S Townsend; Mary C Puckett; Sun Hee Rim
Journal:  J Womens Health (Larchmt)       Date:  2016-03       Impact factor: 2.681

5.  Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.

Authors:  Shamly Austin; Michelle Y Martin; Yongin Kim; Ellen M Funkhouser; Edward E Partridge; Maria Pisu
Journal:  Health Serv Res       Date:  2012-12-03       Impact factor: 3.402

Review 6.  Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions.

Authors:  Sherri L Stewart; Naheed Lakhani; Phaeydra M Brown; O Ann Larkin; Angela R Moore; Nikki S Hayes
Journal:  J Womens Health (Larchmt)       Date:  2013-07-18       Impact factor: 2.681

7.  Caregiver Burden in End-Stage Ovarian Cancer.

Authors:  Joan Hartnett; Bridgette Thom; Nancy Kline
Journal:  Clin J Oncol Nurs       Date:  2016-04       Impact factor: 1.027

Review 8.  Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.

Authors:  Mingo M H Yung; Hextan Y S Ngan; David W Chan
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-01-12       Impact factor: 3.848

9.  Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.

Authors:  Kristin Weeks; Charles F Lynch; Michele West; Ryan Carnahan; Michael O'Rorke; Jacob Oleson; Megan McDonald; Sherri L Stewart; Mary Charlton
Journal:  Gynecol Oncol       Date:  2020-11-18       Impact factor: 5.482

10.  Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.

Authors:  Ying-Cheng Chiang; Chi-An Chen; Chun-Ju Chiang; Tsui-Hsia Hsu; Ming-Chieh Lin; San-Lin You; Wen-Fang Cheng; Mei-Shu Lai
Journal:  J Gynecol Oncol       Date:  2013-10-02       Impact factor: 4.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.